These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 37198085)
1. Implementation of the standardized process of Pharmacotherapeutic evaluation in inpatients and outpatients. González A; Gutiérrez W; Fuenzalida T; Lizana F; Gutiérrez M; Severino N Farm Hosp; 2023; 47(6):254-260. PubMed ID: 37198085 [TBL] [Abstract][Full Text] [Related]
2. [Translated article] Implementation of the standardized process of drug therapy evaluation in inpatients and outpatients. González A; Gutiérrez W; Fuenzalida T; Lizana F; Gutiérrez M; Severino N Farm Hosp; 2023; 47(6):T254-T260. PubMed ID: 37735005 [TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical orientation at hospital discharge of transplant patients: strategy for patient safety. Lima LF; Martins BC; Oliveira FR; Cavalcante RM; Magalhães VP; Firmino PY; Adriano LS; Silva AM; Flor MJ; Néri ED Einstein (Sao Paulo); 2016; 14(3):359-365. PubMed ID: 27759824 [TBL] [Abstract][Full Text] [Related]
4. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study. Muñoz-Pichuante D; Villa-Zapata L J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354 [TBL] [Abstract][Full Text] [Related]
6. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital. Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146 [TBL] [Abstract][Full Text] [Related]
7. Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar. Abushanab D; Atchan M; Elajez R; Elshafei M; Abdelbari A; Al Hail M; Abdulrouf PV; El-Kassem W; Ademi Z; Fadul A; Abdalla E; Diab MI; Al-Badriyeh D PLoS One; 2023; 18(6):e0286419. PubMed ID: 37262042 [TBL] [Abstract][Full Text] [Related]
8. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service. Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815 [TBL] [Abstract][Full Text] [Related]
9. Implementing a clinical pharmacy service in hematology. Farias TF; Aguiar KD; Rotta I; Belletti KM; Carlotto J Einstein (Sao Paulo); 2016; 14(3):384-390. PubMed ID: 27759828 [TBL] [Abstract][Full Text] [Related]
10. A cost avoidance study of critical care pharmacists' interventions in a tertiary institution in Singapore. Chan LEJ; Soong JL; Lie SA Am J Health Syst Pharm; 2023 Feb; 80(5):267-283. PubMed ID: 36371740 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in Italy. Lombardi N; Wei L; Ghaleb M; Pasut E; Leschiutta S; Rossi P; Troncon MG BMC Health Serv Res; 2018 Apr; 18(1):259. PubMed ID: 29631587 [TBL] [Abstract][Full Text] [Related]
12. Impact of collaborative pharmaceutical care on in-patients' medication safety: study protocol for a stepped wedge cluster randomized trial (MEDREV study). Leguelinel-Blache G; Castelli C; Roux-Marson C; Bouvet S; Andrieu S; Cestac P; Collomp R; Landais P; Loulière B; Mouchoux C; Varin R; Allenet B; ; Bedouch P; Kinowski JM Trials; 2018 Jan; 19(1):19. PubMed ID: 29310711 [TBL] [Abstract][Full Text] [Related]
13. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic. Shahrami B; Sefidani Forough A; Najmeddin F; Hadidi E; Toomaj S; Javadi MR; Gholami K; Sadeghi K J Clin Pharm Ther; 2022 Jul; 47(7):964-972. PubMed ID: 35218217 [TBL] [Abstract][Full Text] [Related]
14. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit. Saokaew S; Maphanta S; Thangsomboon P Pharm Pract (Granada); 2009 Apr; 7(2):81-7. PubMed ID: 25152782 [TBL] [Abstract][Full Text] [Related]
15. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients. Aghili M; Neelathahalli Kasturirangan M JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331 [TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital. Albayrak A; Başgut B; Bıkmaz GA; Karahalil B BMC Health Serv Res; 2022 Jan; 22(1):79. PubMed ID: 35033079 [TBL] [Abstract][Full Text] [Related]
17. Impact of pharmacist-led medication management in care transitions. Yang S BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369 [TBL] [Abstract][Full Text] [Related]
18. Cost benefit analysis of clinical pharmacist interventions in medical intensive care unit in Palestine medical complex: Prospective interventional study. Houso A; Hamdan M; Falana H Saudi Pharm J; 2022 Dec; 30(12):1718-1724. PubMed ID: 36601501 [TBL] [Abstract][Full Text] [Related]
19. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Kopp BJ; Mrsan M; Erstad BL; Duby JJ Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956 [TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of clinical pharmacy service using integrated health system in tertiary care hospital. Amir M; Zehra A; Munawar R; Gul W; Fatima T; Khan Y; Jaffery R; Babar ZU Expert Rev Pharmacoecon Outcomes Res; 2024 Apr; 24(4):533-539. PubMed ID: 38362677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]